Twist Bioscience Corporation · NASDAQ:TWST
Leproust Emily M. sold 41,570 Twist Bioscience Corporation shares (Form 4)
Traded Aug 25, 2026 · Filed Aug 27, 2026
On Aug 25, 2026, Leproust Emily M. (Director, Chief Executive Officer) sold 41,570 Twist Bioscience Corporation shares at an average US$151.98 for US$6.32M under a trading plan, leaving 770,729 shares. Filed Aug 27, 2026 (Form 4).
- Sold
- 41,570 shares
- Price
- US$151.98 average (US$150.56 to US$154.45)
- Value
- US$6.32M
- Holding after
- 770,729 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | Sale | 12,648 | US$150.56 | 799,651 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 12,236 | US$151.36 | 787,415 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 6,412 | US$152.75 | 781,003 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 9,181 | US$153.93 | 771,822 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 1,093 | US$154.45 | 770,729 | Direct |
Source
Related
- Twist Bioscience Corporation
- Leproust Emily M.
- Twist Bioscience Corporation shareholders
- Form 4 · Leproust Emily M. · Oct 7, 2026
- Form 4 · Leproust Emily M. · Oct 5, 2026
- Form 4 · Leproust Emily M. · Sep 25, 2026
- Form 4 · Leproust Emily M. · Sep 23, 2026
- Form 4 · Leproust Emily M. · Sep 21, 2026
- Form 4 · Laponis Adam · Oct 13, 2026
- Form 4 · Green Paula · Oct 5, 2026
- Form 4 · Laponis Adam · Oct 5, 2026
- Form 4 · Finn Patrick John · Oct 5, 2026
- Form 4 · Werner Robert F. · Oct 5, 2026